An innovative Turkish company founded in 2013 and operated in Ankara, focuses on additive manufacturing and 3D printing technologies as a result of its no geometry boundaries philosophy. The company aims to replace metal or polymeric implants with biodegradable alternatives that also have the ability to deliver drugs in a controlled fashion at the defect site. Many patients need craniomaxillofacial implants as a result of work accidents, congenital deficiencies and diseases like cancer. Craniomaxillofacial bone loss cases are primarily operated with custom made implants which are made from metal or plastic material. However, none of the metal or plastic implants can be applied to patients before the age of 20. These patients are currently treated with either using patients own bone or using a highly customized implant made from metals or plastic. However, using patients own bone and using metal or plastic implants has two major downsides. These techniques cannot be applied to children since their pediatric development still continues and treatments with these techniques have the risk of infections. With the biodegradability that company offers, craniomaxillofacial surgery is made possible for children and it improves healing progress with bioactive agents that deliver through controlled release mechanisms. This alternative approach with a scale-up potential became possible with the advancements in 3D printing due to its groundbreaking properties in terms of customization capabilities and ease of logistics with the use of digital 3D models. For their custom made implants, the company is looking for reliable R&D partners such as institutes and universities experienced on custom made implants; additive manufacturing process development; preclinical/clinical trial evaluation of the medical devices; medical device directive (MDD) and/or medical device regulation (MDR); know-how on tissue engineering and/or orthopaedics and also for commercialization stages of a Eurostars project proposal on custom made biodegradable craniomaxillofacial implants. Project duration will be 104 weeks, the deadline for expression of interest is 03/07/2020 and the deadline for the call is 03/09/2020.